# Inflammatory Markers as Predictors of the Efficacy of Electroconvulsive Therapy (ECT) in Major Depression Patients

> **NCT06439797** · — · COMPLETED · sponsor: **The Chaim Sheba Medical Center** · enrollment: 18 (actual)

## Conditions studied

- Major Depressive Disorder
- Healty Controls

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06439797
- **Lead sponsor:** The Chaim Sheba Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-29
- **Primary completion:** 2020-07-09
- **Final completion:** 2020-07-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06439797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06439797, "Inflammatory Markers as Predictors of the Efficacy of Electroconvulsive Therapy (ECT) in Major Depression Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06439797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*